OMCL and SFBS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 4, 2024.

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Omnicell, Inc. (NASDAQ:OMCL ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President Randall Lipps - Founder, Chairman, President an...

Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.57 per share a year ago.

Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.

A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).

Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum.

Revenues decreased in 2023 and will continue declining in 2024 as healthcare centers are reducing their capital investments due to increased operating costs. Profit margins decreased significantly ...

Omnicell's (OMCL) fourth-quarter 2023 performance favorably reflects a heightened focus on managing costs.

Omnicell, Inc. (OMCL) Q4 2023 Earnings Call Transcript

Omnicell (OMCL) plans to focus on integrating customer success functions into its broader organizational structure.

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference.

Omnicell (OMCL) accelerates its shift to cloud-based solutions and tech-enabled services through the launch of Inventory Optimization Service and Central Pharmacy Dispensing Services.

Investors are optimistic about Omnicell (OMCL) due to its technology and innovative solutions.